
M2K Biosciences uses AI to help biotech teams extract insights from genomics data and design antibodies for targeted therapies. The company applies AI informatics and genomics analysis to discover and optimize antibody candidates. Its offering fits the B2B biotech and biopharma market as a technology and services provider. It targets researchers and drug developers who integrate with life science workflows. The platform aims to accelerate precision medicine by enabling faster, data-driven antibody development.

M2K Biosciences uses AI to help biotech teams extract insights from genomics data and design antibodies for targeted therapies. The company applies AI informatics and genomics analysis to discover and optimize antibody candidates. Its offering fits the B2B biotech and biopharma market as a technology and services provider. It targets researchers and drug developers who integrate with life science workflows. The platform aims to accelerate precision medicine by enabling faster, data-driven antibody development.